Tower Research Capital (TRC)’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,654
Closed -$574 6273
2023
Q3
$574 Sell
3,654
-29
-0.8% -$8 ﹤0.01% 5534
2023
Q2
$950 Sell
3,683
-256
-6% -$72 ﹤0.01% 5515
2023
Q1
$1K Sell
3,939
-6,915
-64% -$3.61K ﹤0.01% 5688
2022
Q4
$5K Buy
10,854
+6,395
+143% +$6.44K ﹤0.01% 4947
2022
Q3
$4K Buy
4,459
+1,256
+39% +$2.22K ﹤0.01% 5317
2022
Q2
$9K Buy
3,203
+1,813
+130% +$7.62K ﹤0.01% 4615
2022
Q1
$10K Sell
1,390
-1,823
-57% -$15.1K ﹤0.01% 4390
2021
Q4
$45K Buy
3,213
+2,807
+691% +$55.3K ﹤0.01% 2849
2021
Q3
$10K Sell
406
-1,175
-74% -$37.2K ﹤0.01% 4364
2021
Q2
$73K Buy
1,581
+642
+68% +$30.4K ﹤0.01% 2695
2021
Q1
$41K Sell
939
-954
-50% -$46.4K ﹤0.01% 3299
2020
Q4
$58K Sell
1,893
-141
-7% -$4.47K ﹤0.01% 2959
2020
Q3
$65K Buy
+2,034
New +$49.9K ﹤0.01% 3426

Other funds holding AMTI

Tower Research Capital (TRC)'s AMTI Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q4 2023, closing a stake of 3,654 shares — an estimated $574 sold.

Tower Research Capital (TRC) first reported a position in AMTI in Q3 2020 and held it in 13 quarters. The position peaked at $73K in Q2 2021. 2 funds tracked by Wall St. Rank hold AMTI as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,654 Applied Molecular Transport Inc. Common Stock shares in Q4 2023, an estimated $574.
  • Tower Research Capital (TRC) first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Applied Molecular Transport Inc. Common Stock position peaked at $73K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.